Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Disease area: Sleep and breathing disorders

Abstract

Background: Only very few small studies have analyzed the role of CPAP treatment on blood pressure (BP) levels in patients with resistant hypertension (RH)
Objective:To evaluate the effect of CPAP treatment on BP levels in patients with RH
Methods: Multicenter-randomized study. 210 patients with RH (BP>130/80 mmHg despite 3 antihypertensive drugs) of unknown etilogy, confirmed by 24h-ambulatory monitorization [AMPA], and sleep apnea (AHI>15) were randomized to usual control plus CPAP (n=105) or only usual control (n=105) both for three months. Variables derived from AMPA including daytime and night-time BP values and nocturnal patterns were compared intra- and inter- randomized groups. Good adherence to CPAP was considerated as ≥4 hours/day.
Results: Mean age 57.9 (68% males). Mean AHI 40.4. 24h-mean systolic /diastolic blood pressure (SBP/DBP):143/82.5 mmHg. 75% with non-dipper pattern. Patients with good adherence to CPAP (mean use: 5.9 h/d) have a net decrease of -5.5 mmHg in SBP (p<0.001) and -4.2 mmHg in DBP (p<0.001), especially in nocturnal SBP (-7.5 mmHg; p<0.001). There is a positive correlation between the increase used of CPAP in hours/d and the decrease in BP levels (r=0.25; p=0.014). 28% of patients in CPAP group vs 17.5% in control group normalized their BP levels; p=0.045). More patients in CPAP group significantly recovered their dipper pattern, compared with control group (p=0.008)
Conclusions: CPAP treatment significantly decrease SBP and DBP levels and allowed the recovering of normal dipper pattern in patients with RH and sleep apnea. The magnitude of these effects correlate with the number of hours of CPAP use.

Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Martínez-García, F. Capote, F. Campos-Rodriguez, P. Lloberes, M. J. Diaz de Atauri, M. Somoza, F. Masa, M. Gonzalez, L. Sacristan, F. Barbé, J. Duran-Cantolla, J. M. Montserrat, On Behalf of Spanish Sleep Network (Valencia, Seville, Barcelona, Madrid, Terrassa, Cáceres, Santander, Alicante, Lleida, Vitoria, Spain). LATE-BREAKING ABSTRACT: Effect of CPAP treatment on blood pressure levels in resistant hypertension. A multicenter randomized study from the Spanish sleep network (NCT00616265). Eur Respir J 2012; 40: Suppl. 56, 3864

Member's Comments

No comment yet.

Related content which might interest you: Effect of continuous positive airway pressure (CPAP) on resistant hypertension. A randomised, controlled study Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Effect of the continuous positive airway pressure in apneic patients with resistant hypertension: results from the randomized controlled RHOOSAS study Source: International Congress 2017 – CPAP therapy Year: 2017 LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2. Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019 Prospective cohort study of patients complaining of high pressure with CPAP/APAP (PAP) who switch to bi-level PAP (VAuto) as second-line therapy: POP-IN study Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Impact of a short rehabilitation program on fat visceral and blood pressure on patients with obstructive sleep apnea syndrome (OSAS). A randomized controlled study Source: Annual Congress 2007 - Pulmonary rehabilitation beyond training Year: 2007 PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH) Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 The effect of early use of continuous positive airway pressure (CPAP) therapy to treat acute atelectasis after cardiac surgery: Randomized study Source: Annual Congress 2011 - Sleep and weight: heavy under pressure Year: 2011 LATE-BREAKING ABSTRACT: Treating the most diseased segments in patients with severe emphysema: 6 month results from the STEP-UP randomized controlled trial (RCT) Source: International Congress 2015 – Advances in therapeutic bronchoscopy Year: 2015 Fixed pressure (FP) versus auto-adjusting continuous positive airway pressure (autoCPAP): Comparison of efficacy in reducing blood pressure, a randomized controlled trial Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013 Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019 Year: 2020 Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study Source: Eur Respir J 2001; 18: 630-634 Year: 2001 The Pickwick randomized clinical trial: long-term positive airway pressure therapy in obesity hypoventilation syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Effect of 3-month CPAP treatment on blood pressure and serum aldosterone concentration in patients with resistant hypertension Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013 Late Breaking Abstract - FACE: Cluster phenotyping predicting outcomes in a prospective multicenter cohort study of chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV). Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019 CPAP impact on memory processes in OSA patients, a randomized sham controlled trial Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016 Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Mandibular advancement device versus continuous positive airway pressure for treatment of obstruvtive sleep apnea syndrome: a randomized crossover trial Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 52 (4) 1801177; 10.1183/13993003.01177-2018 Year: 2018